Graf Akcie APDN (Applied Dna Sciences Inc). Diskuze k akciím APDN. Aktuální informace APDN.

Základní informace o společnosti Applied Dna Sciences Inc (Akcie APDN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 42.67M
Hodnota podniku (EV) N/A
Tržby 6.302M
EBITDA N/A
Zisk -13.90
Růst v tržbách Q/Q 294.03 %
Růst v tržbách Y/Y 91.53 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.41
EV/Sales 5.61
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 6.64
P/FCF N/A
Price/Book 7.32
Účetní hodnota na akcii 0.78
Hotovost na akcii 1.07
FCF vůči ceně -34.19 %
Počet zaměstnanců 60
Tržba na zaměstnance 105.033k
Profit margin -674.46 %
Operating margin -201.67 %
Gross margin 62.68 %
EBIT margin -220.27 %
EBITDA margin -452.18 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -36.11 %
EPS - Očekávaný růst příští rok -47.44 %
Return on assets -94.24 %
Return on equity -121.75 %
ROIC -173.06 %
ROCE -88.90 %
Dluhy/Equity 0.98
Čistý dluh/EBITDA 3.29
Current ratio 8.70
Quick Ratio 8.43
Volatilita 5.75
Beta 0.49
RSI 56.22
Cílová cena analytiků 22
Známka akcie (dle analytiků) N/A
Insider ownership 10.46 %
Institutional ownership 27.04 %
Počet akcií 7.486M
Procento shortovaných akcií 8.08 %
Short ratio 0.28 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2002
Země United States

Finanční výsledky akcie APDN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1.932$5.389$3.903$4.751$4.186$9.009
Cost Of Goods Sold$0.721$0.878$1.207$1.077$1.171$0.384
Gross Profit$1.211$4.512$2.697$3.674$3.016$8.624
Research And Development Expenses$3.322$2.967$2.752$2.282$3.701$2.577
SG&A Expenses$10.138$10.278$11.044$13.325$10.808$13.41
Other Operating Income Or Expenses------
Operating Expenses$14.467$14.513$15.55$17.571$16.386$16.863
Operating Income$-12.535$-9.124$-11.646$-12.82$-12.2$-7.854
Total Non-Operating Income/Expense$-0.494$0.507$-0.047$-0.036$0.024$-4.027
Pre-Tax Income$-13.029$-8.617$-11.693$-12.856$-12.176$-11.881
Income Taxes-$0.015----
Income After Taxes$-13.029$-8.632$-11.693$-12.856$-12.176$-11.881
Other Income------
Income From Continuous Operations$-13.029$-8.632$-11.693$-12.856$-12.176$-11.881
Income From Discontinued Operations------
Net Income$-13.03$-8.933$-11.693$-12.856$-12.176$-11.881
EBITDA$-12.223$-8.71$-11.097$-12.187$-11.493$-7.363
EBIT$-12.535$-9.124$-11.646$-12.82$-12.2$-7.854
Basic Shares Outstanding411110
Shares Outstanding411110
Basic EPS$-3.32$-9.69$-15.86$-19.60$-20.40$-25.20
EPS - Earnings Per Share$-3.32$-9.69$-15.86$-19.60$-20.40$-25.20
# 2020 2019 2018 2017 2016 2015
Current Ratio2.1280.95561.41824.81622.7794.325
Long-term Debt / Capital0.08312.21780.6777---
Debt/Equity Ratio0.4109-1.82122.1029---
Gross Margin62.676683.71569.082677.327572.03795.7344
Operating Margin-648.9784-169.3101-298.3675-269.8261-291.4145-87.184
EBIT Margin-648.9784-169.3101-298.3675-269.8261-291.4145-87.184
EBITDA Margin-632.8381-161.6232-284.2956-256.4965-274.5387-81.7376
Pre-Tax Profit Margin-674.5496-159.9054-299.5619-270.576-290.8441-131.8881
Net Profit Margin-674.6094-165.7558-299.5619-270.576-290.8441-131.8881
Asset Turnover0.17031.51180.69290.58270.26890.5792
Inventory Turnover Ratio1.44946.15315.45163.29973.9315-
Receiveable Turnover9.93986.4162.62691.83590.65672.2925
Days Sales In Receivables36.72156.8894138.9494198.8123555.8049159.2134
ROE - Return On Equity-228.19671017.358-1549.787-187.4544-117.4675-94.5434
Return On Tangible Equity-270.3771461.96012959.589-232.4472-142.3406-111.2186
ROA - Return On Assets-114.8814-242.1624-207.552-157.6631-78.2225-76.3848
ROI - Return On Investment-209.2326-1238.914-499.4557-187.4543-117.4675-94.5434
Book Value Per Share1.1102-0.70241.002310.020217.21923.3748
Operating Cash Flow Per Share4.60051.93621.96115.3671-1.995510.4813
Free Cash Flow Per Share4.40232.22371.8216.27320.78877.2499